KR840006222A - 피페리딘 유도체의 제조방법 - Google Patents

피페리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR840006222A
KR840006222A KR1019830004475A KR830004475A KR840006222A KR 840006222 A KR840006222 A KR 840006222A KR 1019830004475 A KR1019830004475 A KR 1019830004475A KR 830004475 A KR830004475 A KR 830004475A KR 840006222 A KR840006222 A KR 840006222A
Authority
KR
South Korea
Prior art keywords
formula
represent
compound
different
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019830004475A
Other languages
English (en)
Korean (ko)
Inventor
멘트로프(외 4) 안톤
Original Assignee
기젤라 벨만, 피터 페르호프
베링거 인겔하임 케이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 기젤라 벨만, 피터 페르호프, 베링거 인겔하임 케이지 filed Critical 기젤라 벨만, 피터 페르호프
Publication of KR840006222A publication Critical patent/KR840006222A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
KR1019830004475A 1982-09-25 1983-09-24 피페리딘 유도체의 제조방법 Withdrawn KR840006222A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3235565.3? 1982-09-25
DE19823235565 DE3235565A1 (de) 1982-09-25 1982-09-25 Piperidinderivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
KR840006222A true KR840006222A (ko) 1984-11-22

Family

ID=6174159

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830004475A Withdrawn KR840006222A (ko) 1982-09-25 1983-09-24 피페리딘 유도체의 제조방법

Country Status (23)

Country Link
US (1) US4539323A (enExample)
EP (1) EP0104445A3 (enExample)
JP (1) JPS5978187A (enExample)
KR (1) KR840006222A (enExample)
AU (1) AU561118B2 (enExample)
CA (1) CA1215981A (enExample)
CS (1) CS235342B2 (enExample)
DD (1) DD212517A5 (enExample)
DE (1) DE3235565A1 (enExample)
DK (1) DK436583A (enExample)
ES (4) ES8501762A1 (enExample)
FI (1) FI833292L (enExample)
GR (1) GR78973B (enExample)
HU (1) HU191637B (enExample)
IL (1) IL69777A (enExample)
NO (1) NO833423L (enExample)
NZ (1) NZ205716A (enExample)
PH (1) PH20015A (enExample)
PL (1) PL139590B1 (enExample)
PT (1) PT77380B (enExample)
SU (1) SU1187720A3 (enExample)
YU (1) YU192183A (enExample)
ZA (1) ZA837081B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
JPS62212385A (ja) * 1986-03-13 1987-09-18 Kotobuki Seiyaku Kk キナゾリン誘導体並びに血圧降下剤及びその製法
US7799794B2 (en) * 2000-06-28 2010-09-21 Merck Sharp & Dohme Corp. Treatment for cardiovascular disease
WO2004003223A2 (en) 2002-07-01 2004-01-08 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
FR2854633B1 (fr) * 2003-05-07 2005-06-24 Sanofi Synthelabo Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
FR2866885B1 (fr) * 2004-02-26 2007-08-31 Sanofi Synthelabo Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309541A (en) * 1978-09-20 1982-01-05 Ciba-Geigy Corporation Piperidinyl-lactams
EP0009465A1 (de) * 1978-09-20 1980-04-02 Ciba-Geigy Ag N-(1-(4-Amino-2-chinazolinyl)-3- oder -4-piperidyl-lactame, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen
FR2483920A1 (fr) * 1980-06-09 1981-12-11 Synthelabo Nouveaux derives de quinazoline, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
PL243878A1 (en) 1985-01-02
ES534349A0 (es) 1985-04-01
US4539323A (en) 1985-09-03
DK436583D0 (da) 1983-09-23
ES8504180A1 (es) 1985-04-01
PT77380A (de) 1983-10-01
PT77380B (de) 1986-03-20
YU192183A (enExample) 1986-12-31
DE3235565A1 (de) 1984-03-29
ES525876A0 (es) 1984-12-01
ES534350A0 (es) 1985-04-01
IL69777A (en) 1986-09-30
ES8501762A1 (es) 1984-12-01
ZA837081B (en) 1985-05-29
EP0104445A3 (de) 1985-07-10
ES8504182A1 (es) 1985-04-01
FI833292A7 (fi) 1984-03-26
CA1215981A (en) 1986-12-30
DK436583A (da) 1984-03-26
PH20015A (en) 1986-08-28
AU1939683A (en) 1984-03-29
CS235342B2 (en) 1985-05-15
NZ205716A (en) 1985-08-30
PL139590B1 (en) 1987-02-28
JPS5978187A (ja) 1984-05-04
GR78973B (enExample) 1984-10-02
DD212517A5 (de) 1984-08-15
ES534351A0 (es) 1985-04-01
AU561118B2 (en) 1987-04-30
NO833423L (no) 1984-03-26
EP0104445A2 (de) 1984-04-04
FI833292L (fi) 1984-03-26
HU191637B (en) 1987-03-30
SU1187720A3 (ru) 1985-10-23
ES8504181A1 (es) 1985-04-01
FI833292A0 (fi) 1983-09-15

Similar Documents

Publication Publication Date Title
KR840004406A (ko) 히단토인의 제조방법
KR870003998A (ko) 퀴나졸린 유도체류의 제조방법
BR9002311A (pt) Composto e processo para sua preparacao,composicao fungicida e processo para controlar fungos fitopatogenicos
KR840001175A (ko) [3H]-이미다조 [5,1-d]-1,2,3,5- 테트라진-4-온 유도체의 제조방법
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
KR840001148A (ko) 헤테로사이클릭 치환기를 가지는 설포닐우레아의 제조방법
KR840003260A (ko) [(3-아미노-3-카르복시)-프로필-1]포스핀산 유도체의 제조법
KR840006222A (ko) 피페리딘 유도체의 제조방법
KR830005090A (ko) 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔 산(酸)
KR850007601A (ko) 페남 유도체의 제조방법
SE8801518D0 (sv) A novel process
KR850001907A (ko) 구충제 화화물 및 조성물의 제조방법
KR850002460A (ko) 카르바메이트 화합물의 제조방법
KR890006620A (ko) 퀴놀린 유도체 및 그의 제조법
KR850005847A (ko) 피리미도[2,1-b] 벤조티아졸 및 그것의 염들의 제조방법
KR840006481A (ko) 테트라졸화합물의 제조방법 및 이들화합물을 유효성분으로 하는 항균 및 항미 조성물
KR830006160A (ko) 1-아릴-사이클로프로판-1-카복실산 에스테르의 제조방법
KR840003627A (ko) 4-피페라지닐-4-페닐 퀴나졸린 유도체의 제조방법
ATE123286T1 (de) Verfahren zur herstellung von 3-alkoxymethyl cephalosporinderivate.
KR850001754A (ko) 5-티옥소-2-이미다졸리닐 벤조산, 에스테르, 염의제법
KR850004587A (ko) 치환된 n-페닐-n'-아실이소티오우레아의 제조방법
KR850005448A (ko) 펜옥시 프로피오닐옥시 알칸 포스포네이트의 제조방법
KR840004735A (ko) 시클로프로판 카르복실산 유도체의 제조방법 및 조성물
KR860004051A (ko) 치환된 페닐피페라진 유도체의 제조방법
KR860002474A (ko) 치환된 페닐술포닐아졸의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830924

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid